AORT Stock: Price, Earnings History and SEC Filings
Artivion, Inc. (AORT) last traded at $22.58, down 3.67% on the latest session and down 1.1% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.13 against an analyst estimate of $0.13, a beat of 0.0%.
$22.58 -3.67%
1 month-1.05%
52-week high$48.25
52-week low$19.16
Volume627,382
ExchangeNYSE
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
AORT earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $0.13 | $0.13 | +0.00% |
| Mar 2026 | May 7, 2026 | $0.08 | $0.06 | +33.33% |
| Dec 2025 | Feb 12, 2026 | $0.17 | $0.14 | +21.43% |
| Sep 2025 | Nov 6, 2025 | $0.16 | $0.14 | +14.29% |
AORT beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for AORT
SEC filing data is not available right now. You can search for AORT on SEC EDGAR.
AORT news
- Artivion to Participate in Upcoming Investor ConferencesOct 28, 2026 · finance.yahoo.com
- OrthoPediatrics (KIDS) Reports Q3 Loss, Tops Revenue EstimatesOct 27, 2026 · finance.yahoo.com
- Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2026 Financial ResultsOct 22, 2026 · finance.yahoo.com
- Medical devices & supplies - cardiology, neurology, vascular stocks Q2 teardown: Artivion (NYSE:AORT) vs the restOct 22, 2026 · finance.yahoo.com
- Artivion rises as Jefferies initiates at buy, sees ’attractive entry point’Oct 20, 2026 · finance.yahoo.com
- Artivion (AORT) Stock May Be 13% Undervalued On Cash FlowOct 20, 2026 · finance.yahoo.com
About Artivion, Inc.
Artivion, Inc. (AORT) is a US-listed public company on NYSE.